Is Piper Sandler Companies (NYSE:PIPR) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Piper Sandler Companies at current levels.
Mid-market M&A boutique riding the deal cycle back to peak earnings, with a municipal franchise nobody bothers to value separately.
Where PIPR is headed
Piper Sandler exits 2027 looking like a different business than the one the market still prices. The advisory franchise, anchored by Sandler O'Neill in financials and the legacy healthcare practice, is heading into the fattest part of an M&A cycle that started thawing in mid-2025 and now has private equity sponsors sitting on roughly $1.6 trillion of aging dry powder that has to be deployed before LP patience snaps. Mid-market deals, the $500m to $5bn range where Piper actually competes, are where the bid-ask gap closed first. Goldman and Morgan Stanley fight over the megadeals. Piper eats the volume.
Read the full Compass Direction on PIPR
The complete destination call, the overlooked angle, milestones, and bull, base, and bear price scenarios (around $77.24).
See the full PIPR analysisGet calls like this, free
Join the Alexandria e-letter for forward-looking verdicts, earnings intelligence, and the contrarian reads the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is Piper Sandler Companies (NYSE:PIPR) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Piper Sandler Companies at current levels. Mid-market M&A boutique riding the deal cycle back to peak earnings, with a municipal franchise nobody bothers to value separately.
What is PIPR's Compass Score?
Piper Sandler Companies scores 76/100 on Alexandria's Compass, placing it in the "Favorable" tier. Scores blend eight factors and update weekly.
What is the price target for PIPR?
Alexandria's full Compass Direction includes bull, base, and bear price scenarios with the valuation math behind each. Read the full breakdown on the PIPR page.
Compass verdicts are AI-generated, forward-looking editorial research from publicly available data, not investment advice or a recommendation regarding any security. Scores and verdicts update as the data changes.